Management of jaundice and prevention of severe neonatal hyperbilirubinemia in infants ≥35 weeks gestation

Neonatology

Volumn 94, Issue 1, 2008, Pages 63-67

  Bhutani, Vinod K ^a,b   Maisels, M Jeffrey ^c   Stark, Ann R ^d   Buonocore, Giuseppe ^e  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PENNSYLVANIA HOSPITAL   (United States)

^c WILLIAM BEAUMONT HOSPITAL   (United States)

^d TEXAS CHILDREN S HOSPITAL   (United States)

^e UNIVERSITY OF SIENA   (Italy)

Author keywords

Hyperbilirubinemia; Jaundice; Kernicterus

Indexed keywords

IMMUNOGLOBULIN;

AMBULATORY CARE; BREAST FEEDING EDUCATION; CONFERENCE PAPER; DISEASE SEVERITY; FOLLOW UP; GESTATIONAL AGE; HEALTH CARE PERSONNEL; HEALTH EDUCATION; HUMAN; KERNICTERUS; LACTATION; MEDICAL INFORMATION; NEWBORN JAUNDICE; OUTCOME ASSESSMENT; PATIENT SAFETY; PHOTOTHERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR;

HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INFANT, NEWBORN; JAUNDICE, NEONATAL; KERNICTERUS; PRACTICE GUIDELINES AS TOPIC;

EID: 46049098575     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000113463     Document Type: Conference Paper

References (39)

1. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia: Maisels MJ, Baltz RD, Bhutani VK, Newman TB, Palmer H, Rosenfeld W, et al: Clinical practice guideline: management of hyperbilirubinemia in the newborn infant ≥35 weeks of gestation. Pediatrics 2004;114:297-316. http:// www.aappolicy.aappublications.org/cgi/content/full/pediatrics;114/1/297.
2. Ip S, Glicken S, Kulig J, Obrien R, Sege R, Lau J: Management of Neonatal Hyperbilirubinemia. Rockville, US Department of Health and Human Services, Agency for Healthcare Research and Quality. 03, E011. 2003. http:// www.ahrq.gov/clinic/epcsums/neonatalsum.pdf.
3. Joint Commission on Accreditation of Healthcare Organizations (JCAHO). Revised Guidance to Help Prevent Kernicterus. Sentinel Event Alert: Issue No. 31. August 31, 2004, pp 1-4. http://www.jointcommission. org/SentinelEvents/ SentinelEventAlert/sea_31.htm.
4. Bhutani VK, Johnson LH, Maisels MJ, Newman TB, Phibbs C, Stark AR, Yeargin-Allsopp M: Kernicterus: epidemiological strategies for its prevention through systems-based approaches. J Perinatol 2004;24:650-662.
5. Ebbesen F: Recurrence of kernicterus in term and near-term infants in Denmark. Acta Paediatr 2000;89:1213-1217.
6. Manning DJ, Maxwell MJ, Todd PJ, Platt MJ: Prospective surveillance study of severe hyperbilirubinaemia in the newborn in the United Kingdom and Ireland. Arch Dis Child Fetal Neonatal Ed 2007;92:F342-346.
7. Sgro M, Campbell D, Shah V: Incidence and causes of severe neonatal hyperbilirubinemia in Canada. CMAJ 2006;175:587-590.
8. Ostrow JD, Pascolo L, Shapiro SM, Tiribelli C: New concepts in bilirubin encephalopathy (review). Eur J Clin Invest 2003;33:988-997.
9. Shapiro SM: Definition of the clinical spectrum of kernicterus and bilirubin-induced neurologic dysfunction (BIND). J Perinatol 2005;25:54-59.
10. Wennberg RP, Ahlfors CE, Bhutani VK, Johnson LH, Shapiro SM: Toward understanding kernicterus: a challenge to improve the management of jaundiced newborns. Pediatrics 2006;117:474-485.
11. Ostrow JD, Pascolo L, Brites D, Tiribelli C: Molecular basis of bilirubin-induced neurotoxicity (invited review). Trends Mol Med 2004;10:65-70.
12. Tiribelli C, Ostrow JD: The molecular basis of bilirubin encephalopathy and toxicity: report of an EASL Single Topic Conference, Trieste, Italy, 1-2 October, 2004. J Hepatol 2005;43:156-166.
13. Watchko JF: Genetics and the risk of neonatal hyperbilirubinemia. Pediatr Res 2004;56:677-678.
14. Newman TB, Liljestrand P, Jeremy RJ, Ferriero DM, Wu YW, Hudes ES, Escobar GJ; Jaundice and Infant Feeding Study Team: Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more. N Engl J Med 2006;354:1889-1900.
15. Watchko JF: Vigintiphobia revisited. Pediatrics 2005;115:1747-1753.
16. Newman TB, Xiong B, Gonzales VM, Escobar GJ: Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr Adolesc Med 2000;154:1140-1147.
17. Ebbesen F, Andersson C, Verder H, Grytter C, Pedersen-Bjergaard L, Petersen JR, Schaarup J: Extreme hyperbilirubinaemia in term and near-term infants in Denmark. Acta Paediatr 2005;94:59-64.
18. Petersen JR, Okorodudu AO, Mohammad AA, Fernando A, Shattuck KE: Association of transcutaneous bilirubin testing in hospital with decreased readmission rate for hyperbilirubinemia. Clin Chem 2005;51:540-544.
19. Stevenson DK, Wong RJ, Vreman HJ: Reduction in hospital readmission rates for hyperbilirubinemia is associated with use of transcutaneous bilirubin measurement. Clin Chem 2005;51:481-482.
20. Maisels MJ, Kring E: Transcutaneous bilirubin levels in the first 96 h in a normal newborn population of ≥35 weeks' gestation. Pediatrics 2006;117:1169-1173.
21. Ho HT, Ng TK, Tsui KC, Lo YC: Evaluation of a new transcutaneous bilirubinometer in Chinese newborns. Arch Dis Child Fetal Neonatal Ed 2006;91:F434-F438.
22. Bhutani VK, Johnson L: Kernicterus in late preterm infants cared for as term healthy infants. Semin Perinatol 2006;30:89-97.
23. Huang MJ, Kua KE, Teng HC, Tang KS, Weng HW, Huang CS: Risk factors for severe hyperbilirubinemia in neonates. Pediatr Res 2004;56:682-689.
24. Palmer RH, Keren R, Maisels MJ, Yeargin-Allsopp M: National Institute of Child Health and Human Development (NICHD) conference on kernicterus: a population perspective on prevention of kernicterus. J Perinatol 2004;24:723-725.
25. Lannon C, Stark AR: Closing the gap between guidelines and practice: ensuring safe and healthy beginnings. Pediatrics 2004;114:494-496.
26. Bhutani VK, Johnson LH, Schwoebel A, Gennaro S: A systems approach for neonatal hyperbilirubinemia in term and near-term newborns. J Obstet Gynecol Neonatal Nurs 2006;35:444-455.
27. Eggert LD, Wiedmeier SE, Wilson J, Christensen RD: The effect of instituting a prehospital-discharge newborn bilirubin screening program in an 18-hospital health system. Pediatrics 2006;117:e855-e862.
28. Smitherman H, Stark AR, Bhutani VK: Early recognition of neonatal hyperbilirubinemia and its emergent management. Semin Fetal Neonatal Med 2006;11:214-224.
29. Dollberg G, Mimouni M, Dollberg S: Computerized decision-making assistance for managing neonatal hyperbilirubinemia. Pediatrics 2006;117:262-263.
30. Blackmon LR, Fanaroff AA, Raju TNK: Research on prevention of bilirubin-induced brain injury and kernicterus: National Institute of Child Health and Human Development Conference Executive Summary. Pediatrics 2004;114:229-233.
31. Stevenson DK, Wong RJ, Vreman HJ, McDonagh AF, Maisels MJ, Lightner DA: NICHD Conference on Kernicterus: Research on Prevention of Bilirubin-Induced Brain Injury and Kernicterus: Bench-to-Bedside-Diagnostic Methods and Prevention and Treatment Strategies. J Perinatol 2004;24:521-525.
32. Kaplan M, Hammerman C: Glucose-6-phosphate dehydrogenase deficiency: a hidden risk for kernicterus. Semin Perinatol 2004;28:356-364.
33. Kaplan M, Muraca M, Vreman HJ, Hammerman C, Vilei MT, Rubaltelli FF, Stevenson DK: Neonatal bilirubin production-conjugation imbalance: effect of glucose-6-phosphate dehydrogenase deficiency and borderline prematurity. Arch Dis Child Fetal Neonatal Ed 2005;90:F123-F127.
34. Gourley GR, Li Z, Kreamer BL, Kosorok MR: A controlled, randomized, double-blind trial of prophylaxis against jaundice among breastfed newborns. Pediatrics 2005;116:385-391.
35. Newman TB, Liljestrand P, Escobar GJ: Combining clinical risk factors with serum bilirubin levels to predict hyperbilirubinemia in newborns. Arch Pediatr Adolesc Med 2005;159:113-119.
36. Keren R, Bhutani VK, Luan X, Nihtianova S, Cnaan A, Schwartz JS: Identifying newborns at risk of significant hyperbilirubinaemia: a comparison of two recommended approaches. Arch Dis Child 2005;90:415-421.
37. McDonagh AF: Ex uno plures: the concealed complexity of bilirubin species in neonatal blood samples. Pediatrics 2006;118:1185-1187.
38. Roca L, Calligaris S, Wennberg RP, Ahlfors CE, Malik SG, Ostrow JD, Tiribelli C: Factors affecting the binding of bilirubin to serum albumins: validation and application of the peroxidase method. Pediatr Res 2006;60:724-728.
39. Gordo AC, Falcao AS, Fernandes A, Brito MA, Silva RF, Brites D: Unconjugated bilirubin activates and damages microglia J Neurosci Res 2006;84:194-201.